Key Points
- CEO Dagi Shahar Ben-Noon purchased 18,181 shares of Inspira Technologies at an average price of $1.67, increasing his direct stake by 0.50% to 3.66 million shares. He also bought 168,894 shares in late September.
- Inspira reported a quarterly loss of $0.07 per share on $0.78 million in revenue, while the stock traded within a 52-week range of $0.28 to $3.85.
- Analyst sentiment remains negative, with the company carrying a consensus “Sell” rating. Inspira has also authorized a buyback of up to 5.6% of its outstanding shares.
Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX - Get Free Report) CEO Dagi Ben-Noon purchased 18,181 shares of the business's stock in a transaction on Friday, October 9th. The shares were bought at an average price of $1.67 per share, with a total value of $30,362.27. Following the purchase, the chief executive officer directly owned 3,664,314 shares in the company, valued at approximately $6,119,404.38. The trade was a 0.50% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Dagi Shahar Ben-Noon also recently made the following trade(s):
- On Monday, September 28th, Dagi Ben-Noon acquired 168,894 shares of Inspira Technologies OXY B.H.N. stock. The shares were bought at an average cost of $0.71 per share, with a total value of $119,914.74.
Inspira Technologies OXY B.H.N. Price Performance
Shares of Inspira Technologies OXY B.H.N. stock opened at $1.87 on Friday. Inspira Technologies OXY B.H.N. Ltd has a 52 week low of $0.28 and a 52 week high of $3.85. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.00 and a quick ratio of 1.62. The business has a 50 day moving average of $0.96.
Inspira Technologies OXY B.H.N. (NASDAQ:QTEX - Get Free Report) last announced its earnings results on Thursday, September 24th. The company reported ($0.07) earnings per share (EPS) for the quarter. The company had revenue of $0.78 million during the quarter.
Inspira Technologies OXY B.H.N. declared that its Board of Directors has authorized a stock repurchase plan on Monday, June 22nd that authorizes the company to buy back 2,000,000,000,000 shares. This buyback authorization authorizes the company to buy up to 5.6% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board believes its stock is undervalued.
Wall Street Analysts Forecast Growth
Several analysts have recently issued reports on the stock. Weiss Ratings upgraded shares of Inspira Technologies OXY B.H.N. from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, September 25th. Wall Street Zen lowered shares of Inspira Technologies OXY B.H.N. from a "hold" rating to a "sell" rating in a research report on Saturday, August 8th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company has a consensus rating of "Sell".
Check Out Our Latest Stock Report on QTEX
About Inspira Technologies OXY B.H.N.
(
Get Free Report)
Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company's technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.
Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
